Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial
Barrett-Lee, Peter, Prof, Casbard, Angela, MSc, Abraham, Jacinta, FRCR, Hood, Kerenza, Prof, Coleman, Robert, Prof, Simmonds, Peter, FRACP, Timmins, Hayley, BSc, Wheatley, Duncan, FRCR, Grieve, Robert, FRCR, Griffiths, Gareth, PhD, Murray, Nick, DPhil
Published in The lancet oncology (2014)
Published in The lancet oncology (2014)
Get full text
Journal Article